BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8589203)

  • 1. Urinary protein C inhibitor binding region in the A alpha-chain of human fibrinogen.
    Hayashi S; Wakizaka A
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):382-7. PubMed ID: 8589203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary protein C inhibitor binding region in the B beta-chain of human fibrinogen.
    Hayashi S
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):921-6. PubMed ID: 8148485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the cross-linking site of GPRVVERHK in the gamma-chain of human fibrinogen.
    Cierniewski CS; Budzynski AZ
    Eur J Biochem; 1993 Dec; 218(2):321-5. PubMed ID: 8269920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human fibrinogen heterogeneity: the COOH-terminal residues of defective A alpha chains of fibrinogen II.
    Nakashima A; Sasaki S; Miyazaki K; Miyata T; Iwanaga S
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):361-70. PubMed ID: 1420813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and partial structural characterization of an equine fibrinogen CNBr fragment that exhibits immunologic cross-reactivity with an A alpha-chain cross-linking region of human fibrinogen.
    Sobel JH; Thibodeau CA; Kolks MA; Canfield RE
    Biochemistry; 1990 Sep; 29(38):8907-16. PubMed ID: 2271566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic peptide fragmentation of polyvinylidene difluoride(PVDF)-immobilized proteins prior to microsequencing.
    Iwamatsu A; Yoshida-Kubomura N
    J Biochem; 1996 Jul; 120(1):29-34. PubMed ID: 8864840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution 2-D peptide mapping with subsequent analysis of peptides by microsequencing or lectin binding directly from PVDF membrane blots.
    Lopez MF; Barry P; Sawlivich WB; Hines T; Skea WM
    Appl Theor Electrophor; 1994; 4(2):95-102. PubMed ID: 7880884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsequence analysis of the N-terminally blocked proteins immobilized on polyvinylidene difluoride membrane by western blotting.
    Hirano H; Komatsu S; Kajiwara H; Takagi Y; Tsunasawa S
    Electrophoresis; 1993 Sep; 14(9):839-46. PubMed ID: 8223391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deblocking and subsequent microsequence analysis of N alpha-blocked proteins electroblotted onto PVDF membrane.
    Hirano H; Komatsu S; Takakura H; Sakiyama F; Tsunasawa S
    J Biochem; 1992 Jun; 111(6):754-7. PubMed ID: 1323565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of nucleic acid binding in proteolytic domains of HIV-1 reverse transcriptase.
    Kumar A; Kim HR; Sobol RW; Becerra SP; Lee BJ; Hatfield DL; Suhadolnik RJ; Wilson SH
    Biochemistry; 1993 Jul; 32(29):7466-74. PubMed ID: 7687875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of amino acid compositions and NH2-terminal sequences of peptides electroblotted onto PVDF membranes from tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis: application to peptide mapping of human complement component C3.
    Ploug M; Jensen AL; Barkholt V
    Anal Biochem; 1989 Aug; 181(1):33-9. PubMed ID: 2817381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroblotting proteolytic products from native gel for direct N-terminal sequence analysis: an approach for studying protein-protein interaction.
    Wang F; Su C; Hollfelder K; Waddington D; Pan YC
    Electrophoresis; 1993 Sep; 14(9):847-51. PubMed ID: 8223392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogenolysis by a neutrophil membrane protease generates an A alpha 1-21 fragment.
    Kelly SL; Adams SA; Robson SC; Kirsch RE; Shephard EG
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):689-95. PubMed ID: 8141784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial sequencing of the XL-I form of xenobiotic-metabolizing medium chain fatty acid:CoA ligase from bovine liver mitochondria, and its homology with the essential hypertension protein.
    Vessey DA; Kelley M
    Biochim Biophys Acta; 1997 Jun; 1346(3):231-6. PubMed ID: 9219907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain structure of the 90-kDa stress protein: heparin- and antibody-binding domain.
    Itoh H; Tashima Y
    Int J Biochem; 1993 Feb; 25(2):157-61. PubMed ID: 7680324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor.
    Kojro E; Eich P; Gimpl G; Fahrenholz F
    Biochemistry; 1993 Dec; 32(49):13537-44. PubMed ID: 8257689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial characterization of the 30 kD Ig-binding protein from Pseudomonas maltophilia.
    Grover S; Odell WD
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1075-81. PubMed ID: 1540156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s).
    Akiyama M; Sugatani J; Suzuki T; Suzuki Y; Miwa M
    J Biochem; 1998 May; 123(5):786-9. PubMed ID: 9562606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
    Matsuka YV; Medved LV; Migliorini MM; Ingham KC
    Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.